Alaunos Therapeutics Insider Trades

TCRT

Track insider trading activity from Alaunos Therapeutics executives and directors. See which insiders are buying and selling TCRT stock.

Trades Last 12 Months

TCRT Price

All Insider Trades for Alaunos Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Weis Holger Chief Executive Officer
Holding Value $12.9k 4,911 shares
Last Trade
May 22, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.77k 3,700 shares
$2.37
$2.62
Postma Robert W Director
Holding Value $131k 50,146 shares
Last Trade
Apr 29, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$16.2k 6,274 shares
$2.59
$2.62
Vieser Jaime Director
Holding Value $102k 38,853 shares
Last Trade
Apr 29, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$16.9k 6,515 shares
$2.59
$2.62
Holding Value $40.9k 15,621 shares
Last Trade
Apr 29, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15.6k 6,032 shares
$2.59
$2.62
Groenewald Ferdinand Vice President Of Finance
Holding Value $28.2k 10,775 shares
Last Trade
Aug 18, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.28k 4,000 shares
$2.32
$2.62
Hogue Dale Curtis Jr. See Remarks
Holding Value $7.86k 3,000 shares
Last Trade
Mar 29, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.38k 3,000 shares
$1.46
$2.62
Lackey Melinda Legal & Administration
Holding Value $2.62k 1,000 shares
Last Trade
Mar 29, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.46k 1,000 shares
$1.46
$2.62
Holding Value $33.5k 12,800 shares
Last Trade
Jun 06, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$132k 12,800 shares
$10.30
$2.62
Boyle Kevin S. Sr. Chief Executive Officer
Holding Value $2.09M 798,236 shares
Last Trade
Sep 01, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.47M 68,014 shares
$21.57
$2.62
Huang James Director
Holding Value $262k 100,000 shares
Last Trade
Jun 06, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.12M 100,000 shares
$71.24
$2.62
Thistle Mary Director
Holding Value $262k 100,000 shares
Last Trade
Jun 06, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.12M 100,000 shares
$71.24
$2.62
Wong Michael Vice President, Finance
Holding Value $328k 125,000 shares
Last Trade
Mar 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.33M 125,000 shares
$74.63
$2.62
Deniger Drew See Remarks
Holding Value $328k 125,000 shares
Last Trade
Mar 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.33M 125,000 shares
$74.63
$2.62
Srivastava Abhishek K See Remarks
Holding Value $328k 125,000 shares
Last Trade
Mar 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.33M 125,000 shares
$74.63
$2.62
Holding Value $262k 100,000 shares
Last Trade
Jun 22, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$12.3M 100,000 shares
$122.87
$2.62
De Groot Eleanor Evp, Operations
Holding Value $917k 350,000 shares
Last Trade
Mar 30, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$69.7M 700,000 shares
$99.51
$2.62
Hagen Heidi Director
Holding Value $382k 145,889 shares
Last Trade
Sep 02, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$6.31M 23,770 shares
$265.50
$2.62
Baffa Raffaele Chief Medical Officer
Holding Value $735k 280,645 shares
Last Trade
May 17, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$37.9M 80,645 shares
$469.50
$2.62
Buchi J Kevin Director
Holding Value $81.9k 31,250 shares
Last Trade
Mar 04, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20.2M 31,250 shares
$646.50
$2.62
Buck Jill Evp, GM Gene Therapy
Holding Value $619k 236,250 shares
Last Trade
Mar 04, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$173M 267,750 shares
$646.50
$2.62

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up